Vaccitech plc
VACC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.07 | -0.25 | -0.00 | 0.10 |
| FCF Yield | -8.37% | -14.28% | -11.75% | 5.69% |
| EV / EBITDA | -4.76 | 4,062.39 | 120.48 | -2.99 |
| Quality | ||||
| ROIC | 0.15% | 0.01% | 0.25% | 44.41% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 159.21% |
| Cash Conversion Ratio | 0.74 | 0.86 | 0.76 | -0.47 |
| Growth | ||||
| Revenue 3-Year CAGR | -22.26% | -13.30% | -8.67% | -3.18% |
| Free Cash Flow Growth | 40.87% | -21.69% | -311.27% | 161.72% |
| Safety | ||||
| Net Debt / EBITDA | 4.57 | -5,713.15 | -265.04 | 11.65 |
| Interest Coverage | 12.00 | 1.08 | 25.31 | -879.76 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 26.55 |